 NEWTON, Mass., Dec. 7, 2020 PRNewswire -- Karyopharm Therapeutics Inc. Nasdaq: KPTI, a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced an oral presentation highlighting data related to XPOVIO selinexor, the Companys first-in-class, oral... 